ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,702.55
      -0.19%
      US Tech 100
      19,287.60
      -0.24%
      Dow Jones
      42,063.36
      0.09%
      Brent Oil
      74.475
      0.80%
      Bitcoin
      64,285.93
      1.04%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Eterna Therapeutics Inc (ERNA) Quote

      Eterna Therapeutics Inc

      Eterna Therapeutics Inc (ERNA)

      Is $ul-sh Bd A
      1.28
      0.02
      (1.59%)
      Closed September 23 4:00PM
      Delayed by 15 minutes
      1.27
      -0.01
      (-0.78%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      1.28
      Bid
      0.62
      Ask
      9.47
      Volume
      12,081
      1.26 Day's Range 1.365
      0.840101 52 Week Range 2.625
      Market Cap
      6.926M
      Previous Close
      1.26
      Open
      1.26
      Last Trade
      1
      @
      1.28
      Last Trade Time
      Financial Volume
      $ 15,621
      VWAP
      1.293
      Average Volume (3m)
      8,793
      Shares Outstanding
      5,410,588
      Dividend Yield
      -
      PE Ratio
      -0.32
      Earnings Per Share (EPS)
      -4.01
      Revenue
      68k
      Net Profit
      -21.68M

      About Eterna Therapeutics Inc

      Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indicati... Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Television Broadcast Station
      Website
      eternatx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      2022
      Eterna Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ERNA. The last closing price for Eterna Therapeutics was $1.26. Over the last year, Eterna Therapeutics shares have traded in a share price range of $ 0.840101 to $ 2.625.

      Eterna Therapeutics currently has 5,410,588 shares outstanding. The market capitalization of Eterna Therapeutics is $6.82 million. Eterna Therapeutics has a price to earnings ratio (PE ratio) of -0.32.

      Ask ADVFN Intelligence (AI)

      ERNA Latest News

      More News

      Form 8-K - Current report

      August 19 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 13 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      May 14 2024
      Edgar (US Regulatory)

      Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MSCs i

      The presentation reports the development of a beta 2 microglobulin-knockout (B2M-KO) iMSC line with enhanced immunosuppressive activity and stealthing features that may further augment the...

      May 10 2024
      GlobeNewswire Inc.

      Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to its Scientific Advisory Board

      CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a preclinical-stage biopharmaceutical company, committed to realizing the...

      May 08 2024
      GlobeNewswire Inc.

      Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on the Development of a mRNA-Engineered iPSC Line which Mimics Native B2M Expression, via Targeted Insertion of HLA-E at the B2M Locus

      Eterna reports the development of an mRNA-engineered iPSC line developed using UltraSlice™ to express a B2M-HLA-E fusion transgene in lieu of the endogenous B2M gene product to mimic native B2M...

      May 07 2024
      GlobeNewswire Inc.

      Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors

      CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science company committed to realizing the potential of mRNA cell...

      February 20 2024
      GlobeNewswire Inc.

      Form 3 - Initial statement of beneficial ownership of securities

      February 16 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      February 16 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.265-17.15210355991.5451.581.26127371.33765118CS
      4-0.58-31.18279569891.861.921.2683041.52391512CS
      12-0.48-27.27272727271.762.6251.2687931.78261212CS
      26-0.92-41.81818181822.22.6251.2677731.92286828CS
      52-0.9-41.28440366972.182.6250.840101149461.60935401CS
      156-2.92-69.52380952384.27.150.840101317233.644275CS
      260-2.92-69.52380952384.27.150.840101317233.644275CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BNZIBanzai International Inc
      $ 5.645
      (96.01%)
      		61.39M
      ZJYLJin Medical International Ltd
      $ 3.975
      (50.00%)
      		1.24M
      ANEBAnebulo Pharmaceuticals Inc
      $ 2.9001
      (39.43%)
      		78.85k
      XPONExpion360 Inc
      $ 0.081
      (39.18%)
      		1.46B
      AENTAlliance Entertainment Holding Corporation
      $ 2.74
      (34.31%)
      		4.23M
      GSIWGarden Stage Ltd
      $ 1.34
      (-82.89%)
      		26.44M
      CRBPCorbus Pharmaceuticals Holdings Inc
      $ 19.51
      (-62.26%)
      		12.29M
      LGCBLinkage Global Inc
      $ 0.4183
      (-57.70%)
      		2.16M
      BFIBurgerFi International Inc
      $ 0.0855
      (-42.27%)
      		15.05M
      SKYESkye Bioscience Inc
      $ 3.17
      (-42.26%)
      		5.14M
      XPONExpion360 Inc
      $ 0.081
      (39.18%)
      		1.46B
      NVDANVIDIA Corporation
      $ 116.00
      (-1.59%)
      		378.16M
      AAPLApple Inc
      $ 228.20
      (-0.29%)
      		320.24M
      INTCIntel Corporation
      $ 21.84
      (3.31%)
      		261.68M
      VERBVerb Technology Company Inc
      $ 0.0742
      (33.45%)
      		178.65M

      Discussion

      View Full Feed
      linkvest linkvest 1 minute ago
      I like your opinion better than mine lol. I'm trying to be conservative. I've see so many good stocks hit that nickel and run to a buck over the years. Can IGPK do that? Why not?
      IGPK
      linkvest linkvest 4 minutes ago
      Yep,,, but I think we should see .01 by noon..... Morning can't get here soon enough for me lol....
      IGPK
      cojoboy cojoboy 4 minutes ago
      Thinking...60-.85..but..what do I know..
      IGPK
      Slojab Slojab 5 minutes ago
      Try making sense. For a change.
      USEI
      BDEZ BDEZ 5 minutes ago
      U.S. presidents net worth before and after office

      https://x.com/alifarhat79/status/1837885422858313981
      cojoboy cojoboy 6 minutes ago
      It's been running..slow..but..sure..😎😎😎👌👌👌
      IGPK
      lakers17 lakers17 8 minutes ago
      SoBull on Solano is hot. I didn't buy it. My bigger meme hopefuls are BRETT on Base, Wolf on Solana and BULL on TRON. A new one LEMON on ETH is also screaming hot but I don't like buying once they have gone up. The big holders are in low and control the action. Way too many memes now and many o
      CanItBThisEZ2Make CanItBThisEZ2Make 10 minutes ago
      BEST SELLERS RANK (BSR) IS 720 46 Estimated Sold on Amazon Since JULY 1 - 3RD Quarter 2024
      https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
      https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

      NOTE: In theory, when BSR Value De
      SRMX
      linkvest linkvest 11 minutes ago
      I think their company is large enough and has plenty of employees that they can do a few things at once. Once all of this starts to get finished like the name change and symbol change along with the audited financials in the next month this beast will be running big time. I can't imagine where this
      IGPK
      dstock07734 dstock07734 12 minutes ago
      Mike Taylor showed up again talking about something about hotels. Check at 33:30.
      https://youtu.be/xZ4O521yYAQ?list=PLaXuKAateIQ4FRcuVe1qPRR7Qo_ndfoNk&t=2018
      NWBO
      fuagf fuagf 13 minutes ago
      Gotta say, Why. "Johnson previously tried to pass a spending bill with the SAVE Act attached—a Trump-endorsed bill that would ban
      states from registering non-citizens as voters. Fourteen Republicans joined Democrats to defeat the bill last week." Even though the answer is clear. It's nonsen
      rocket7878 rocket7878 17 minutes ago
      Wouldn’t it be sweet if the SEC responded to the new external audits that the prior filings needed correction and that catchup be the precursor to audit approval … jump starting whatever is coming. Mr Fytton told Billy he was hoping for SEC approval a month ago this may be part of it.
      GEGP
      maperatpogi maperatpogi 17 minutes ago
      This is good news.
      However waiting for what we were told💪Name change and audited financials in September and October. Let's have them first b4 anything else. Goodness.
      $IGPK/JFHE
      IGPK
      linkvest linkvest 21 minutes ago
      Good buy... Going to run soon we bet on that one,
      IGPK
      shajandr shajandr 22 minutes ago
      JAY PATRICK BOOTH begging to felch STEVEN MOSKOWITZ
      carlson carlson 22 minutes ago
      Hoping this UPCOMING WEEK is going to be EPIC!!!
      NBRI
      dinogreeves dinogreeves 23 minutes ago
      This is will be in dollars if the data is blown out of the park and if Alzheimers is anything like their phase 2, it will go to 500-600 million market cap, they also have other indications in their pipeline.
      TGRP
      boobb2 boobb2 23 minutes ago
      If the letter on 08/06/2024 was meant to pump up the share price ..Friedman would have sent the PR to many news outlets instead of only via the OTC...he did not....that tells he is not interested in pumping up the share price on wishful thinking and phony PR's to garner interest.......He is actual
      MCIC
      rocket7878 rocket7878 25 minutes ago
      Hoping so - thanks for all the diligence everyone does watching for these updates. Let’s get out of these triple zeros and hope they are building something great
      GEGP
      EmperorMaestro47 EmperorMaestro47 25 minutes ago
      Not a peep on $TAMG. Hmmm. Hey how come this stock didn't appear on market movers @ 56 % and what say you? No news and I don't read charts yet. 10q
      TAMG

      Your Recent History

      NASDAQ
      ERNA
      Eterna Therapeutics
      Delayed Upgrade Clock